Table 1.
Serotonin receptor binding affinities and activation potencies of 4-alkoxy-substituted 2,5-dimethoxyphenethylamines and amphetamines.
h5-HT1A | h5-HT2A | h5-HT2B | h5-HT2C | Selectivity (binding ratios) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Receptor binding K i ± SD [nM] [3H]8-OH-DPAT |
Receptor binding K i ± SD [nM] [3H]ketanserin |
Activation potency EC50 ± SD [nM] |
Activation efficacy max ± SD [%] |
Activation potency EC50 ± SD [nM] |
Activation efficacy max ± SD [%] |
Receptor binding K i ± SD [nM] [3H]mesulgerine |
5-HT2A/5-HT1A | 5-HT2A/5-HT2C | ||
4-alkoxy-substituted 2,5-dimethoxyphenethylamines | ||||||||||
6 | 2C-O-2 | 3600 ± 400 | 670 ± 90 | 16 ± 3 | 50 ± 10 | 49 ± 44 | 85 ± 17 | 2300 ± 1200 | 5.4 | 3.4 |
7 | 2C-O-3 | 2700 ± 200 | 40 ± 8 | 0.5 ± 0.3 | 70 ± 4 | 68 ± 21 | 50 ± 22 | 150 ± 30 | 68 | 3.8 |
8 | 2C-O-16 | 4500 ± 500 | 140 ± 40 | 4.9 ± 2.5 | 84 ± 4 | 120 ± 70 | 42 ± 13 | 470 ± 40 | 32 | 3.4 |
9 | 2C-O-21 | 5500 ± 0 | 1700 ± 600 | 53 ± 15 | 44 ± 17 | 900 ± 450 | 39 ± 26 | 3600 ± 1900 | 3.2 | 2.1 |
10 | 2C-O-21.5 | 2900 ± 200 | 1000 ± 100 | 2600 ± 1600 | 30 ± 8 | 480 ± 260 | 28 ± 23 | 4200 ± 1500 | 2.9 | 4.2 |
11 | 2C-O-22 | 3300 ± 200 | 440 ± 60 | 460 ± 140 | 35 ± 8 | 250 ± 10 | 28 ± 20 | 1900 ± 400 | 7.5 | 4.3 |
12 | 2C-O-27 | 2700 ± 100 | 8.1 ± 1 | 76 ± 80 | 36 ± 16 | 480 ± 190 | 39 ± 16 | 110 ± 50 | 333 | 14 |
4-alkoxy-substituted 2,5-dimethoxyamphetamines | ||||||||||
13 | MMALM | NA | 61 ± 0 | 1.5 ± 0.1 | 95 ± 4 | 29 ± 13 | 90 ± 13 | 290 ± 110 | >92 | 4.8 |
14 | MALM | >5600 | 150 ± 0 | 2.9 ± 0.5 | 89 ± 10 | 9.5 ± 3.3 | 101 ± 6 | 900 ± 220 | >37 | 6 |
15 | MFEM | >5600 | 1900 ± 900 | 330 ± 180 | 56 ± 36 | 270 ± 210 | 41 ± 22 | 11000 ± 3000 | >2.9 | 5.8 |
16 | MDFEM | >5600 | 980 ± 620 | 140 ± 80 | 48 ± 23 | 130 ± 80 | 21 ± 8 | 6700 ± 2400 | >5.7 | 6.8 |
17 | MTFEM | >5600 | 460 ± 240 | 19 ± 1 | 80 ± 6 | 200 ± 30 | 4.8 ± 3.5 | 2400 ± 800 | >12 | 5.2 |
18 | MIPM | >5600 | 4400 ± 2100 | 990 ± 330 | 47 ± 13 | 180 ± 120 | 20 ±14 | 9030 ± 2390 | >1.4 | 2.1 |
19 | TMA-2 | >17000 | 1300 ± 700 | 190 ± 90 | 84 ± 10 | 270 ± 0 | 78 ± 5 | 5300 ± 1600 | >13 | 4.1 |
Reference substance | ||||||||||
2C-Ba | 311±46 | 6.9 ± 1.8 | 2.1 ± 0.8 | 92 ± 8 | 75 ± 14 | 52 ± 26 | 43 ± 4 | 45 | 6.2 |
Ki and EC50 values are given as nM (mean ± SD); activation efficacy (Emax) is given as percentage of maximum ± SD. NA, not assessed.
Data previously published in (Luethi et al., 2018).